Liu Y, Gong Y, Wang C, Wang X, Zhou Q, Wang D, Guo L, Pi X, Zhang X, Luo S, Li H, Li E
Department of Anesthesiology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Acta Anaesthesiol Scand. 2015 Mar;59(3):319-28. doi: 10.1111/aas.12448. Epub 2015 Jan 7.
Breath analysis of propofol is a potential noninvasive method for approximating the plasma propofol concentration. There have been various reported techniques for measuring the exhaled propofol concentration at steady state; however, the propofol concentration undergoes marked changes during clinical anesthesia. Therefore, this study investigated the use of membrane inlet-ion mobility spectrometry (MI-IMS) to monitor exhaled propofol discontinuously and continuously during propofol anesthesia.
The study included 19 patients of American Society of Anesthesiologists physical status I or II. In experiment I (discontinuous study), breath and blood samples were collected discontinuously, with stable target propofol concentrations of 2.8 μg/ml, 3.2 μg/ml, 3.5 μg/ml, and 3.8 μg/ml. In experiment II (continuous study), propofol concentration was maintained at 3.5 μg/ml after induction, and exhaled breath was collected continuously every 3 min during propofol infusion. Relationships of the exhaled propofol concentration with the plasma propofol concentration, measured by high-performance liquid chromatography and the continuously measured bispectral (BIS) index were investigated.
Comparison of the exhaled and plasma propofol concentrations revealed a bias ± precision of 2.1% ± 14.6% (95% limits of agreement: - 26.5-30.7%) in experiment I and - 10.4% ± 13.2 (- 36.3-15.4%) in experiment II. In both experiments, exhaled propofol concentrations measured by MI-IMS were consistent with, the propofol effect represented by the BIS index.
MI-IMS may be a suitable method to predict plasma propofol concentration online during propofol anesthesia. Monitoring exhaled propofol may improve the safety of propofol anesthesia.
丙泊酚的呼吸分析是一种潜在的非侵入性方法,用于估算血浆丙泊酚浓度。已有多种报道的技术用于测量稳态下呼出的丙泊酚浓度;然而,丙泊酚浓度在临床麻醉期间会发生显著变化。因此,本研究调查了膜进样-离子迁移谱(MI-IMS)在丙泊酚麻醉期间间断和连续监测呼出丙泊酚的应用。
该研究纳入了19例美国麻醉医师协会身体状况I或II级的患者。在实验I(间断研究)中,间断采集呼吸和血液样本,目标丙泊酚稳定浓度为2.8μg/ml、3.2μg/ml、3.5μg/ml和3.8μg/ml。在实验II(连续研究)中,诱导后丙泊酚浓度维持在3.5μg/ml,在丙泊酚输注期间每3分钟连续采集呼出气体。研究了通过高效液相色谱法测量的呼出丙泊酚浓度与血浆丙泊酚浓度以及连续测量的脑电双频指数(BIS)之间的关系。
呼出与血浆丙泊酚浓度的比较显示,实验I中的偏差±精密度为2.1%±14.6%(95%一致性界限:-26.5-30.7%),实验II中为-10.4%±13.2%(-36.3-15.4%)。在两个实验中,通过MI-IMS测量的呼出丙泊酚浓度与BIS指数所代表的丙泊酚效应一致。
MI-IMS可能是在丙泊酚麻醉期间在线预测血浆丙泊酚浓度的合适方法。监测呼出丙泊酚可能会提高丙泊酚麻醉的安全性。